Karyopharm Therapeutics logo
Healthcare & Life Sciences

Karyopharm Therapeutics

Karyopharm Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 4 tracked investors.

series-c-plus
series-c-plus
Stage
4
Investors

About Karyopharm Therapeutics

Based in the United States, Karyopharm Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.

Karyopharm Therapeutics is a clinical-stage pharmaceutical company focused on developing drugs that modulate nuclear transport for the treatment of cancer and related diseases.

Explore Karyopharm Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States